Induction of Tumors in Mouse Bladder by HPA
Author Information
Author(s): D. B. Clayson, G. M. Bonser
Primary Institution: Department of Experimental Pathology and Cancer Research, The School of Medicine, Leeds
Hypothesis
Does 4-ethylsulphonylnaphthalene-1-sulphonamide (HPA) act as a co-carcinogen or a promoting agent for bladder tumors?
Conclusion
HPA is a complete carcinogen that significantly increases the incidence of bladder tumors in female mice compared to males.
Supporting Evidence
- HPA induced carcinomas in 46% of female mice and 15% of male mice.
- Prior administration of DMBA or AAF reduced the incidence of carcinomas in females.
- HPA increased the tumor yield from 4.5% to 19% in mice with paraffin wax pellets.
- HPA was locally active when implanted in the bladder, inducing 22% of carcinomas.
Takeaway
This study shows that a chemical called HPA can cause bladder cancer in mice, especially in females.
Methodology
Hybrid Ab x IF mice were fed HPA in their diet and monitored for tumor development over time.
Limitations
The influence of HPA on tumor yield in mice with unadulterated pellets was not determined.
Participant Demographics
Hybrid Ab x IF mice, both male and female.
Statistical Information
P-Value
0.0037
Statistical Significance
p<0.0037
Want to read the original?
Access the complete publication on the publisher's website